-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$12.50110.08% Upside
CAMP4 Therapeutics Corporation Frequently Asked Questions
-
What analysts cover CAMP4 Therapeutics Corporation?
CAMP4 Therapeutics Corporation has been rated by research analysts at Leerink Partners, Piper Sandler, Craig-Hallum, Goldman Sachs in the past 90 days.